- Home
- / HanAll BioPharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
HanAll BioPharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
₩45.7 K
2024-10-29
Market Capitalization
₩2.3 T
2024-10-29
Revenue
₩155.2 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 91.8B | 108.5B | 88.6B | 101.6B | 110.0B | 134.9B | 138.9B | 155.2B |
| Cost of goods sold | 34.1B | 32.8B | 24.9B | 29.2B | 45.6B | 57.1B | 63.1B | 71.4B |
| Gross profit | 58.0B | 76.0B | 64.2B | 72.7B | 64.4B | 77.8B | 75.9B | 83.9B |
| Gross profit margin, % | 70.1% | 72.4% | 71.5% | 58.6% | 57.7% | 54.6% | 54.1% | |
| Operating expense total | 50.3B | 56.3B | 55.4B | 59.6B | 59.8B | 72.3B | 72.5B | 81.2B |
| Depreciation and amortization | 6.5B | 4.5B | 2.4B | 2.7B | 3.1B | 3.3B | 3.1B | 3.8B |
| EBITDA | 7.7B | 19.7B | 8.7B | 13.1B | 4.6B | 5.4B | 3.3B | 2.6B |
| EBITDA margin, % | 18.2% | 9.9% | 12.9% | 4.1% | 4.0% | 2.4% | 1.7% | |
| EBIT | 1.2B | 15.0B | 6.1B | 9.4B | 1.2B | 577.3M | (72.6M) | (2.1B) |
| EBIT margin, % | 13.9% | 6.9% | 9.2% | 1.1% | 0.4% | -0.1% | -1.4% | |
| Interest income | 1.9B | 2.1B | 2.1B | 719.8M | 1.4B | 1.2B | 490.3M | 263.1M |
| Interest expense | 13.8M | 16.0M | 25.5M | 21.9M | 63.9M | 71.0M | 142.5M | |
| Pre tax profit | 4.0B | 17.5B | 19.2B | 8.7B | 1.9B | 3.2B | (183.2M) | (6.2B) |
| Income tax expense | 696.3M | (1.7B) | (539.2M) | (194.0M) | 1.7B | (306.1M) | 1.6B | (620.7M) |
| Net Income | 3.3B | 19.2B | 19.8B | 8.9B | 251.5M | 3.5B | (1.8B) | (5.6B) |